Carolina Minguillón
Carolina Minguillón publishes mostly in Psychiatry and Mental health, Physiology and Molecular Biology, on topics such as Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Functional Brain Connectivity Studies.
- World rank
- #586,053 of 7,710,434 ranked researchers
- Rank in Spain
- #10,886 of 204,306
- Works
- 288
- Citations
- 7.6k
- Citations per work
- 26.4
What does Carolina Minguillón research?
Carolina Minguillón's work is mostly in Medicine (42%), Neuroscience (12%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences12041.7%
- Medicine12041.7%
- Everything else9934.3%
- Life Sciences5820.0%
- Physical Sciences124.0%
- Environmental Science124.0%
- 1Psychiatry and Mental health25% of their works
- 2Physiology17% of their works
- 3Molecular Biology8% of their works
- 4Cognitive Neuroscience8% of their works
- 5Neurology4% of their works
- 6Health, Toxicology and Mutagenesis4% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Alzheimer's disease research and treatments
- Functional Brain Connectivity Studies
- Developmental Biology and Gene Regulation
- Cancer-related cognitive impairment studies
- Health, Environment, Cognitive Aging
- Neurological Disease Mechanisms and Treatments
- Advanced Neuroimaging Techniques and Applications
Which keywords describe Carolina Minguillón's research?
The keywords of their largest research topics: Biomarkers, Neuroimaging, Alzheimer's Disease, Mild Cognitive Impairment, Oxidative Stress, Amyloid Hypothesis, Tau Pathology and Functional Connectivity.
- Vascular Cognitive Impairment
- Cerebral Hypoperfusion
- Environmental Exposure
- Development
- Chemotherapy
- Functional Connectivity
- Amyloid Hypothesis
- Mild Cognitive Impairment
- Neuroimaging
- Biomarkers
- Alzheimer's Disease
- Oxidative Stress
- Tau Pathology
- Resting-State fMRI
- Cognitive Function
- Notch Signaling
- Exposome
- Diffusion MRI
- White Matter
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Biomarkers1992 topics
- Neuroimaging1962 topics
- Alzheimer's Disease1801 topic
- Mild Cognitive Impairment1801 topic
- Oxidative Stress1292 topics
- Amyloid Hypothesis1131 topic
- Tau Pathology1131 topic
- Functional Connectivity311 topic
- Resting-State fMRI311 topic
- Chemotherapy211 topic
- Cognitive Function211 topic
- Development211 topic
- Notch Signaling211 topic
- Environmental Exposure191 topic
- Exposome191 topic
- Cerebral Hypoperfusion161 topic
- Diffusion MRI161 topic
- Vascular Cognitive Impairment161 topic
- White Matter161 topic
Where does Carolina Minguillón work?
Carolina Minguillón's main affiliation in the publication record is Pasqual Maragall Foundation, Spain.
How many publications and citations does Carolina Minguillón have?
OpenAlex counts 288 works and 7,595 citations for Carolina Minguillón, an h-index of 43, ranking #586,053 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carolina Minguillón. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.